NORTH BRUNSWICK, N.J.--(BUSINESS WIRE)--Advaxis Inc., (OTCBB: ADXS, http://www.advaxis.com), a developmental biotechnology company, will collaborate its research efforts with City of Hope, located in Southern California, on a newly created Listeria-based vaccine.
